Dhansa Labs has updated its corporate website address from https://ambeylab.com/ to https://dhansalabs.com/ with immediate effect. The change follows the company's recent transition from its former name, Ambey Laboratories Limited. This update is part of the company's broader rebranding efforts following the stock exchanges' approval for the name change.

The intimation regarding the website update was submitted to the National Stock Exchange of India Ltd. under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company requested the exchange to update the Corporate Information Section on the NSE portal to reflect the new web address.

Corporate Details

The company, registered with the CIN L74899DL1985PLC020490, operates from its registered office located at Ground Floor, Property No.555 Tarla Mohalla, Ghitorni, South West Delhi-110030 India. The communication was signed by Himanshu Kukreja, the Company Secretary & Compliance Officer.

Dhansa Labs Limited reported a 10.82% year-on-year increase in revenue from operations to ₹14,153.72 lakhs for the financial year ended March 31, 2026. Profit after tax (PAT) grew by 15.47% to ₹552.26 lakhs, while EBITDA stood at ₹1,221.80 lakhs, a growth of 6.31%. The company maintained an EBITDA margin of 8.55% and a PAT margin of 3.87% during the period.

Management outlined a significant capacity expansion initiative in its core agrochemical business, including a planned addition of Atrazine manufacturing capacity. This project involves an estimated investment of approximately ₹30 crores and is expected to commence operations by August 2026. Upon stabilization, the company anticipates the project will generate additional annual revenues of ₹120 crores to ₹140 crores, with an initial target of ₹40 crores in the current year.

Diversification and Subsidiaries

The company is diversifying through its subsidiaries, Dhansa Green Energy Private Limited and Dhansa Biofuels Power Private Limited. Dhansa Green Energy is developing a 15 TPD Compressed Biogas (CBG) project in the Bundi district of Rajasthan with an estimated cost exceeding ₹120 crores. Commercial operations are expected to commence by July 2027. The project includes a lease for 350 acres to cultivate Napier grass, ensuring a sustainable feedstock ecosystem and supporting carbon credit generation.

Dhansa Biofuels Power Private Limited is focusing on biomass pellets. The total planned investment for the BioFuel segment is approximately ₹120 crores. Management stated that financial closure for the CBG project is secured, with ₹85 crores in debt finalized and the remaining funding sourced from warrants issued in August 2025.

Financial Guidance and Metrics

For the upcoming financial year, the company expects revenue growth of approximately 20%. Current capacity utilization stands at 71%. Management addressed concerns regarding working capital utilization, noting that funds raised via IPO were used to reduce creditors, increase debtors, and improve stock levels to mitigate material scarcity issues.